| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | PAYP | Japan | $15.08 | $0.00 | Buy | 9 | 2026 |
#2 | CDE | United States | $16.31 | $709,598,000.00 | Strong Buy | 5 | 1994 |
#3 | FLYW | United States | $14.40 | $623,025,000.00 | Buy | 14 | 2021 |
#4 | VRRM | United States | $4.31 | $132,969,000.00 | Buy | 5 | 2016 |
#5 | DEC | United States | $13.82 | $1,829,142,000.00 | Strong Buy | 8 | 2022 |
#6 | RELY | United States | $18.77 | $1,635,147,000.00 | Buy | 7 | 2021 |
#7 | ORN | United States | $13.63 | $852,260,000.00 | Strong Buy | 4 | 2007 |
#8 | EYE | United States | $15.44 | $1,987,488,000.00 | Strong Buy | 9 | 2017 |
#9 | CXDO | United States | $7.57 | $68,167,000.00 | Strong Buy | 5 | 1999 |
#10 | HNRG | United States | $16.66 | $469,466,000.00 | Strong Buy | 4 | 1995 |
#11 | RUN | United States | $13.36 | $858,578,000.00 | Buy | 20 | 2015 |
#12 | PUMP | United States | $14.74 | $1,269,158,000.00 | Buy | 7 | 2017 |
#13 | OMER | United States | $9.79 | $29,868,000.00 | Strong Buy | 5 | 2008 |
#14 | ASST | United States | $14.10 | $633,489.00 | Strong Buy | 4 | 2022 |
#15 | AVTX | United States | $13.10 | $27,813,137.00 | Strong Buy | 8 | 2015 |
#16 | ACRS | United States | $4.36 | $1,683,000.00 | Strong Buy | 5 | 2015 |
#17 | NRDS | United States | $7.97 | $836,600,000.00 | Buy | 5 | 2021 |
#18 | AMLX | United States | $13.32 | $380,786,000.00 | Strong Buy | 9 | 2021 |
#19 | ARVN | United States | $7.42 | $262,600,000.00 | Buy | 19 | 2018 |
#20 | STTK | United States | $4.58 | $1,000,000.00 | Buy | 7 | 2020 |
#21 | IMNM | United States | $18.58 | $6,941,000.00 | Strong Buy | 10 | 2020 |
#22 | CRVS | United States | $11.12 | $0.00 | Strong Buy | 6 | 2016 |
#23 | RLMD | United States | $5.95 | $13,070.00 | Strong Buy | 5 | 2012 |
#24 | PHAT | United States | $10.13 | $175,110,000.00 | Strong Buy | 6 | 2019 |
#25 | LXEO | United States | $4.37 | $654,000.00 | Strong Buy | 9 | 2023 |
#26 | IBRX | United States | $6.93 | $113,288,000.00 | Strong Buy | 7 | 2015 |
#27 | TARA | United States | $4.16 | $2,948,000.00 | Strong Buy | 5 | 2014 |
#28 | IMRX | United States | $4.27 | $0.00 | Strong Buy | 5 | 2021 |
#29 | ERAS | United States | $11.97 | $0.00 | Strong Buy | 12 | 2021 |
#30 | SBH | United States | $12.08 | $3,701,424,000.00 | Buy | 6 | 2006 |
#31 | TRVI | United States | $13.33 | $0.00 | Strong Buy | 11 | 2019 |
#32 | RLAY | United States | $13.52 | $15,355,000.00 | Strong Buy | 10 | 2020 |
#33 | ENTA | United States | $11.28 | $102,814,000.00 | Strong Buy | 5 | 2012 |
#34 | FHTX | United States | $3.73 | $30,909,000.00 | Strong Buy | 8 | 2020 |
#35 | RVLV | United States | $18.88 | $1,225,682,000.00 | Buy | 12 | 2018 |
#36 | ORIC | United States | $7.28 | $0.00 | Strong Buy | 13 | 2020 |
#37 | FDMT | United States | $8.64 | $85,209,000.00 | Strong Buy | 7 | 2019 |
#38 | SBRA | United States | $18.46 | $774,632,000.00 | Buy | 8 | 2010 |
#39 | RGNX | United States | $6.08 | $10,393,000.00 | Strong Buy | 8 | 2015 |
#40 | ZNTL | United States | $3.66 | $0.00 | Buy | 5 | 2020 |
#41 | VIR | United States | $8.65 | $68,556,000.00 | Strong Buy | 7 | 2019 |
#42 | VSTM | United States | $3.71 | $30,914,000.00 | Strong Buy | 7 | 2011 |
#43 | OLMA | United States | $10.31 | $0.00 | Strong Buy | 10 | 2020 |
#44 | SNDX | United States | $17.34 | $172,352,000.00 | Strong Buy | 13 | 2014 |
#45 | CABA | United States | $3.25 | $0.00 | Strong Buy | 6 | 2019 |
#46 | DBVT | France | $16.59 | $5,636,000.00 | Buy | 7 | 2014 |
#47 | FWRG | United States | $10.18 | $1,222,501,000.00 | Strong Buy | 13 | 2021 |
#48 | CTNM | United States | $11.49 | $0.00 | Buy | 4 | 2024 |
#49 | ACHR | United States | $5.55 | $0.00 | Buy | 6 | N/A |
#50 | HSAI | China | $18.49 | $0.00 | Strong Buy | 4 | 2021 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $20 to Buy (June 6, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.